Stock Events

Stock Events

YS Biopharma

$1.0200

7

+$0.11+12.45% Friday 20:00

Statistics

Day High

-

Day Low

-

52W High

-

52W Low

-

Volume

-

Avg. Volume

-

Mkt Cap

0

P/E Ratio

-

Dividend Yield

-

Dividend

-

Earnings

28AugExpected

Q3 2021

Q4 2021

Q1 2022

Q2 2022

Q3 2022

Q1 2024

Q2 2024

-0.24

-0.07

0.11

0.28

Expected EPS

-0.0935408

Actual EPS

N/A

Financials

-35.85%Profit Margin

Unprofitable

2020

2021

2022

98.04MRevenue

-35.15MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Moderna, Inc. competes in the biotechnology and pharmaceuticals space, focusing on mRNA-based therapies, similar to YS Biopharma's focus on innovative biopharmaceuticals.

BioNTech SE operates in the field of mRNA technology for developing vaccines and therapeutics, directly competing with YS Biopharma's biopharmaceutical innovations.

Novavax, Inc. is involved in the development of vaccines for infectious diseases, competing with YS Biopharma's focus on therapeutic solutions.

Pfizer Inc. is a large pharmaceutical company with a broad product portfolio that includes biopharmaceuticals, competing in various therapeutic areas with YS Biopharma.

Johnson & Johnson

Johnson & Johnson operates in the pharmaceuticals sector, offering a wide range of products that compete with YS Biopharma's biopharmaceutical solutions.

AstraZeneca PLC is a global biopharmaceutical company focusing on the discovery, development, and commercialization of prescription medicines, including those in areas where YS Biopharma operates.

GlaxoSmithKline plc is a healthcare company that researches and develops pharmaceuticals, vaccines, and consumer healthcare products, competing with YS Biopharma in the biopharmaceutical field.

Merck & Co., Inc. is known for its high-quality medicines, vaccines, biologic therapies, and animal health products, competing across several of YS Biopharma's key areas.

Roche Holding AG engages in the pharmaceuticals and diagnostics business, directly competing with YS Biopharma in the development of innovative therapeutic solutions.

Sanofi operates globally in pharmaceuticals, covering a broad range of therapeutic areas and competing with YS Biopharma in the biopharmaceutical and vaccine sectors.

About

LakeShore Biopharma Co., Ltd, a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 2002 and is based in Beijing, China.

Show more...

CEO

Employees

773

Country

Cayman Islands

ISIN

KYG9845F1090

WKN

000A3D4XP

Listings

0 Comments

Share your thoughts

FAQ

What is YS Biopharma stock price today?▼

The current price of YS is $1.02 USD — it has increased by +12.45% in the past 24 hours. Watch YS Biopharma stock price performance more closely on the chart.

What is YS Biopharma stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange YS Biopharma stocks are traded under the ticker YS.

What is YS Biopharma revenue for the last year?▼

YS Biopharma revenue for the last year amounts to 98.04M USD.

What is YS Biopharma net income for the last year?▼

YS net income for the last year is -35.15M USD.

How many employees does YS Biopharma have?▼

As of September 06, 2026, the company has 773 employees.

In which sector is YS Biopharma located?▼

YS Biopharma operates in the Technology sector.

When did YS Biopharma complete a stock split?▼

YS Biopharma has not had any recent stock splits.